bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 19, 2024
The
majority
of
studies
on
extracellular
vesicles
(EVs)
focused
samples
isolated
from
liquid
matrices,
such
as
cell
culture
media
and
blood,
due
to
their
accessibility.
However,
recent
research
highlights
the
emerging
roles
EVs
derived
solid
tissues,
including
brain,
muscles
tumors.
Investigating
matrix
tissues
offers
insights
into
microenvironment
potential
biological
influences
surrounding
cells.
This
study
presents
a
method
for
comparing
EV-enriched
(human
skeletal
muscle
biopsy)
(plasma)
addressing
technical
challenges
minimizing
biases
in
separation
techniques.
By
employing
optimized
protocols
advanced
analytical
techniques,
reveals
differences
biochemical
composition,
nanomechanical
properties,
particle
yield,
size
distribution,
colloidal
stability
between
human
plasma
EVs.
Understanding
these
distinctions
may
contribute
development
novel
diagnostic
assays
muscular
pathologies
shed
light
EVs'
diverse
tissue
environments.
Nanoscale Horizons,
Journal Year:
2024,
Volume and Issue:
10(1), P. 104 - 112
Published: Nov. 7, 2024
Initially
observed
on
synthetic
nanoparticles,
the
existence
of
biomolecular
corona
and
its
role
in
determining
nanoparticle
identity
function
are
now
beginning
to
be
acknowledged
biogenic
particularly
extracellular
vesicles
-
membrane-enclosed
shuttling
proteins,
nucleic
acids,
metabolites
which
released
by
cells
for
physiological
pathological
communication
we
developed
a
methodology
based
fluorescence
correlation
spectroscopy
track
formation
derived
from
human
red
blood
amniotic
membrane
mesenchymal
stromal
when
these
dispersed
plasma.
The
allows
tracking
dynamics
Molecules,
Journal Year:
2024,
Volume and Issue:
29(24), P. 5828 - 5828
Published: Dec. 10, 2024
Extracellular
vesicles
(EVs),
secreted
from
most
cells,
are
small
lipid
membranes
of
30
to
1000
nm
in
diameter
and
contain
nucleic
acids,
proteins,
intracellular
organelles
originating
donor
cells.
EVs
play
pivotal
roles
intercellular
communication,
particularly
forming
niches
for
cancer
cell
metastasis.
However,
derived
cells
exhibit
significant
heterogeneity,
complicating
the
investigation
EV
subtypes
using
ensemble
averaging
methods.
In
this
context,
we
highlight
recent
studies
that
characterize
individual
advanced
techniques,
including
single-fluorescent-particle
tracking,
single-metal-nanoparticle
single-non-label-particle
super-resolution
microscopy,
atomic
force
microscopy.
These
techniques
have
facilitated
high-throughput
analyses
properties
particles
such
as
their
sizes,
compositions,
physical
properties.
Finally,
address
challenges
need
be
resolved
via
single-particle
(-molecule)
imaging
microscopy
future
research.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 20, 2023
Abstract
Extracellular
vesicles
(EVs),
crucial
mediators
of
cell-to-cell
communication,
hold
immense
potential
for
diagnostic
applications
due
to
their
ability
enrich
protein
biomarkers
in
body
fluids.
However,
challenges
isolating
EVs
from
complex
biological
specimens
hinder
widespread
use.
In
this
frame,
integrated
isolation-and-analysis
workflows
are
the
go-to
strategy,
most
which
see
prevalence
immunoaffinity
methods.
Yet,
high
heterogeneity
poses
challenges,
as
proposed
ubiquitous
markers
less
homogenously
prevalent
than
believed,
raising
concerns
about
reliability
downstream
biomarker
discovery
programs.
This
issue
extends
burgeoning
field
engineered
EV-mimetics
and
bio-nanoparticles,
where
conventional
immune-affinity
methods
may
lack
applicability.
Addressing
these
we
introduce
use
Membrane
Sensing
Peptides
(MSP)
“universal”
affinity
ligands
both
EV-analogues.
Employing
a
streamlined
process
integrating
on-bead
capture
vesicle
phenotyping
through
Single
Molecule
Array
(SiMoA)
technology,
showcase
application
MSP
analysis
circulating
blood
derivatives,
eliminating
need
prior
EV
isolation.
Demonstrating
possible
clinical
translation
directly
detect
an
EV-associated
epitope
signature
serum
plasma
samples,
demonstrating
its
distinguishing
patients
with
myocardial
infarction
versus
stable
angina.
At
last,
notably,
exhibits
unique
capability
enable
tetraspanin-lacking
Red
Blood
Cell
derived
(RBC-EVs).
Overall,
unlike
traditional
antibody-based
methods,
probes
work
agnostically,
overcoming
limitations
associated
surface
abundance
or
scarcity.
highlights
advancing
diagnostics
beyond.
Of
note,
represents
also
first-ever
peptide-based
SiMoA
technology.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 19, 2024
The
majority
of
studies
on
extracellular
vesicles
(EVs)
focused
samples
isolated
from
liquid
matrices,
such
as
cell
culture
media
and
blood,
due
to
their
accessibility.
However,
recent
research
highlights
the
emerging
roles
EVs
derived
solid
tissues,
including
brain,
muscles
tumors.
Investigating
matrix
tissues
offers
insights
into
microenvironment
potential
biological
influences
surrounding
cells.
This
study
presents
a
method
for
comparing
EV-enriched
(human
skeletal
muscle
biopsy)
(plasma)
addressing
technical
challenges
minimizing
biases
in
separation
techniques.
By
employing
optimized
protocols
advanced
analytical
techniques,
reveals
differences
biochemical
composition,
nanomechanical
properties,
particle
yield,
size
distribution,
colloidal
stability
between
human
plasma
EVs.
Understanding
these
distinctions
may
contribute
development
novel
diagnostic
assays
muscular
pathologies
shed
light
EVs'
diverse
tissue
environments.